Tag Archives: NICE
NICE deny Leukaemia Patients Life Saving Cancer Drugs
NICE (National Institute for Health and Clinical Excellence) have recently returned their provisional results on Nilotinib and Dasatinib as alternative therapy for Imatinib (Glivec / Gleevec) intolerant patients. Basically they are denying these patients a chance of life on what … Continue reading
CML – NICE – epetition response – Dasatinib (DS) & Nilotinib (NL)
Just a quick post to show the reply to 10 Downing Street’s latest reply to the Dasatinib and Nilotinib petiton and challenge to acceptance as 2nd line therapy for resistant / intolerant Imatinib (aka Glivec, Gleevec). I am not going … Continue reading
Filed under chronic myeloid leukaemia, gleevec, glivec, imatinib, leukaemia, leukaemia research
